Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00271037 · ClinicalTrials.gov registry record

Colpocleisis for Advanced Pelvic Organ Prolapse

A clinical trial of Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
152
Enrollment target
6
Study locations

NCT00271037: Completed study of Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00271037 is a study of Pelvic Organ Prolapse and Stress Urinary Incontinence that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 152 participants, roughly in line with the 141-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target. The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00271037, a study of Pelvic Organ Prolapse and Stress Urinary Incontinence, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
152 participants
Enrollment target
6
Study locations

Study Summary

Pelvic organ prolapse occurs when the pelvic organs (e.g., the uterus or bladder) fall or slide down into the vagina. Pelvic organ prolapse can be corrected with surgery. Some types of surgery try to restore the normal anatomy and function of the vagina (i.e., reconstructive surgery). Other surgery repairs the prolapse by essentially closing the vagina (e.g., colpocleisis or colpectomy), thereby leaving a woman unable to have vaginal intercourse in the future. The use of colpocleisis has not been well-studied. The current literature is lacking sufficient studies of colpocleisis to fully understand its risks and benefits for women considering surgery for prolapse. Traditionally, colpocleisis has been restricted to elderly women thought to be poor medical risks for prolonged reconstructive surgery. This study will describe the postoperative course of women who undergo colpocleisis, with particular attention to the persistence or recurrence of urinary incontinence and patient satisfaction after the colpocleisis prolapse surgery.

Interventions

  • PROCEDURE Colpocleisis prolapse repair surgery
  • PROCEDURE sling or other to treat or prevent stress incontinence

Study Locations (6)

Alabama

  • University of Alabama - Birmingham

Illinois

  • Loyola University - Maywood

Iowa

  • University of Iowa - Iowa City

Maryland

  • Johns Hopkins University - Baltimore

North Carolina

  • University of North Carolina - Chapel Hill

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2004-07
Est. Completion 2007-04

What the finished NCT00271037 record still lists

NCT00271037 is an observational study that tracks outcomes without assigning an intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 141-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target.

The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Colpocleisis prolapse repair surgery is the first listed.

NCT00271037 lists 6 locations in 6 states (Alabama, Illinois, Iowa).

Frequently Asked Questions

What is clinical trial NCT00271037 about?

NCT00271037 is a clinical study titled "Colpocleisis for Advanced Pelvic Organ Prolapse". Pelvic organ prolapse occurs when the pelvic organs (e.g., the uterus or bladder) fall or slide down into the vagina. Pelvic organ prolapse can be corrected with surgery. Some types of surgery try to restore the normal anatomy and function of the vagina (i.e., reconstructive surgery). Other surgery ...

What is the current status of trial NCT00271037?

This trial is currently completed. The enrollment target is 152 participants. The study started on 2004-07. Estimated completion is 2007-04.

What conditions does trial NCT00271037 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse, Stress Urinary Incontinence.

What interventions are being tested in trial NCT00271037?

The interventions under investigation include: Colpocleisis prolapse repair surgery (PROCEDURE), sling or other to treat or prevent stress incontinence (PROCEDURE).

Who is sponsoring clinical trial NCT00271037?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00271037 being conducted?

This trial has 6 study locations across Alabama, Illinois, Iowa, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00271037's enrollment target sits among peer trials

152 11th of 40 higher than 30 of 40 other Pelvic Organ Prolapse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03328078 · 152 participants · Phase 1

    CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • NCT04458532 · 152 participants · NA

    Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

  • NCT04858334 · 152 participants · Phase 2

    APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

  • NCT04993859 · 152 participants

    Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00271037, the US trial registry maintained by the National Library of Medicine. NCT00271037 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.